Trial intelligence / Profile preview

S-1 Plus Cisplatin-based Chemoradiotherapy After Induction DCS for Locally Advanced Gastric Adenocarcinoma

NCT02495493Phase 2Completed

Sponsor
Yonsei University
Start
Jul 2013
Primary completion
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur, cisplatin, docetaxel in gastric adenocarcinoma, sponsored by Yonsei University. Started Jul 2013; status: completed.

02

Drugs

tegafurcisplatindocetaxel
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on NCT02495493.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02495493.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call